Melanotan 2 effects and safety, read straight.

The short version

People use Melanotan 2 for one main thing: a fast, deep tan with little sun. They get more than that. The same peptide cuts appetite, raises libido, and — in men — can trigger erections at odd times. The downsides come bundled: nausea, facial flushing, fatigue, and darkening moles. This page splits the evidence in two.

First, what users report. This is community experience — useful, honest, but anecdotal, not clinical evidence. No doses appear here.

Second, the safety record. These are cautions grounded in published case reports and lab studies, each one cited. This is where the genuinely important context lives: moles and melanoma, kidney injury, prolonged erections, blood pressure, and the simple fact that street product is unregulated and unknown ^[4]. Melanotan 2 is not approved medicine anywhere.

What people report

These are effects reported by the research-use community — anecdotal, not clinical evidence, and not verified by controlled trials. No doses are given. People differ; not everyone gets everything here.

The reasons people seek it out:

• A fast, deep tan with little or no sun. Very commonly reported as the whole point. Skin darkens within days, and users reach a deeper color with far less sun or sunbed time than usual.
• Less appetite, some weight loss. Very commonly reported, often from the first dose. Many feel much less hungry within the hour. Some treat it as a bonus; others find it off-putting.
• Higher libido and spontaneous erections (men). Commonly reported by men, often from the first or second dose — a surge in sex drive and unprompted erections, sometimes hours after injecting. Some welcome it; others find it uncomfortable. Women also report heightened arousal.
• Feeling more attractive and confident. Commonly cited as the reason people keep going despite side effects. Discussions note it can tip into preoccupation with looks.

The unpleasant side, frequently reported:

• Nausea, sometimes vomiting. One of the most consistent effects — typically in the first hour after a dose, worst in the early days, often easing with continued use.
• Facial flushing and feeling hot, usually within minutes to an hour. Short-lived but uncomfortable.
• Darkening of existing moles and freckles. Very commonly reported, often the first visible sign. Spots stand out more sharply than the surrounding skin.
• New moles appearing. A frequent and alarming report among longer-term users — sometimes many at once, sometimes within a day or two of a dose. Often what sends people to a doctor.
• Selective darkening of lips, gums, scars, and genital skin. Conspicuous, out of place, sometimes melasma-like patches on the face.
• Fatigue and a flu-like, run-down feeling in the first days — users call it the "melanotan flu." Usually fades.
• Injection-site reactions: redness, swelling, itching, bruising, small lumps. Usually minor and short-lived.
• An odd urge to stretch and yawn repeatedly after a dose. Strange but described as harmless.
• Uneven, blotchy, long-lasting tan. Frequently reported, especially over time — patchy color, an orange or grey cast, and a tan that lingers and fades unevenly for weeks to months after stopping, with moles staying darker than before.

A note on what people search as melanotan 2 reviews and melanotan 2 reddit: forum write-ups skew toward both the cosmetic payoff and the side-effect bundle above. A published qualitative study of online discussions found the same split — strong cosmetic motivation set against a documented risk gap. None of it is controlled trial data.

Safety and cautions — is Melanotan 2 safe?

Short answer: the long-term safety of Melanotan 2 is unknown, and serious harms are documented in case reports ^[4][6]. Below, each caution is grounded in published work and cited. These are the melanotan 2 dangers the literature actually records — not scare copy.

New, changing, or darkening moles, and melanoma risk. As a non-selective melanocortin agonist acting on MC1R, the peptide drives melanocyte activity across the skin. Case reports describe eruptive new nevi, dysplastic (atypical) moles, and darkening of existing ones after use ^[11][14]. Several reports document melanoma and melanoma in situ in melanotan users ^[10][15], and dermoscopy studies show measurable changes in moles during use ^[13]. The long-term melanoma risk is not established, but the signal is serious — especially with concurrent UV or sunbed exposure. Any new or changing mole during or after use warrants prompt dermatological assessment.

Rhabdomyolysis and acute kidney injury. A published case links Melanotan II injection to systemic toxicity with rhabdomyolysis — severe muscle breakdown that can poison the kidneys ^[16]. A separate case report and literature review describe renal infarction associated with use ^[4]. The mechanisms are not fully understood and may relate to the peptide's effects on blood vessels.

Priapism — prolonged, painful erection. Because melanocortin agonism promotes erections, several case reports describe priapism following melanotan tanning injections, including after apparent overdose ^[17][18]. Priapism is a urological emergency; untreated, it can permanently damage erectile tissue.

Posterior reversible encephalopathy syndrome (PRES). A case report describes PRES — a neurological condition involving brain swelling, presenting with headache, seizures, visual disturbance, and high blood pressure — in association with melanotan use ^[19]. This fits the compound's reported effects on blood pressure and vascular tone.

Blood-pressure (pressor) and cardiovascular effects, plus nausea. Preclinical work on the hemodynamic actions of alpha-MSH analogs shows melanocortin agonists can raise blood pressure, and animal studies show this pressor effect worsens when nitric oxide signaling is impaired ^[20][21]. With the very commonly reported nausea, this points to meaningful cardiovascular and gastrointestinal effects that are poorly characterized in humans using unregulated product.

Unregulated product: contamination, mislabeling, unknown content. Analytical studies of melanotan bought online repeatedly find inaccurate labeling, variable or unverifiable peptide content, and impurities, and the compound shows up in surveys of falsified injectables ^[22][23]. With no quality control, a buyer cannot know the identity, dose, purity, or sterility of what is in the vial — which compounds every other risk.

No approval, unknown long-term safety. Melanotan 2 has never been approved by the FDA or any other regulator for any use, and development never finished late-phase trials ^[25][6]. Regulators and dermatology bodies have specifically warned against melanotan tanning products ^[26]. Treat it strictly as an unapproved research chemical — not a medicine, not a cosmetic.

Not the same as the approved melanocortin drugs. Melanotan 2 is often confused with afamelanotide — an approved melanocortin therapy for the rare condition erythropoietic protoporphyria — and with the separately approved sexual-function melanocortin agonist developed from this peptide family ^[27][28]. Those approvals and their controlled-trial safety data do not extend to Melanotan 2. It is a different, unapproved compound used without medical oversight.

Then and now

Melanotan 2 was designed in the late 1980s at the University of Arizona as a superpotent cyclic copy of alpha-MSH, the natural pigment-stimulating hormone. The goal: promote tanning and photoprotection, and so possibly cut skin-cancer risk ^[25][29]. A pilot Phase I study showed it could darken skin ^[1]; researchers then noticed it also triggered erections, which led to a small erectile-dysfunction study and to a spin-off agonist aimed at sexual dysfunction ^[29].

The tanning program never reached the market. From the mid-2000s an illicit trade emerged — the peptide sold online as unlicensed tanning injections, the so-called "Barbie drug" or "sun-tan jab" — despite repeated warnings from regulators and dermatologists ^[30][6]. It remains an unapproved research chemical with no sanctioned medical or cosmetic use.